Evidence map›Paper›PMID 40552975›Full record

ArticleCancer discovery2025

AAnet Resolves a Continuum of Spatially Localized Cell States to Unveil Intratumoral Heterogeneity.

Aarthi Venkat, Scott E Youlten, Beatriz P San Juan, Carley A Purcell, Shabarni Gupta, Matthew Amodio, Daniel P Neumann, John G Lock, Anton E Westacott, Cerys S McCool and 10 more

Abstract read
In one paragraph

Article in Cancer discovery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. GLUT1 expression, lymphocyte distribution and CD3Journal of experimental & clinical cancer research : CR · 2026
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Aarthi VenkatComputational Biology and Bioinformatics Program, Yale University, New Haven, Connecticut.ORCID 0000-0003-0298-0172
Scott E YoultenDepartment of Genetics, Yale School of Medicine, New Haven, Connecticut.ORCID 0000-0001-9314-2945
Beatriz P San JuanKinghorn Cancer Centre, Garvan Institute of Medical Research, Darlinghurst, Australia.ORCID 0000-0002-7868-6298
Carley A PurcellKinghorn Cancer Centre, Garvan Institute of Medical Research, Darlinghurst, Australia.ORCID 0000-0003-2255-6774
Shabarni GuptaKinghorn Cancer Centre, Garvan Institute of Medical Research, Darlinghurst, Australia.ORCID 0000-0002-8233-5917
Matthew AmodioBroad Institute at MIT and Harvard, Cambridge, Massachusetts.ORCID 0000-0001-9478-0957
Daniel P NeumannUniversity of New South Wales, Kensington, Australia.ORCID 0000-0001-6079-0831
John G LockUniversity of New South Wales, Kensington, Australia.ORCID 0000-0002-3880-4106
Anton E WestacottKinghorn Cancer Centre, Garvan Institute of Medical Research, Darlinghurst, Australia.ORCID 0009-0006-7918-8684
Cerys S McCoolKinghorn Cancer Centre, Garvan Institute of Medical Research, Darlinghurst, Australia.ORCID 0009-0005-3055-704X
Daniel B BurkhardtDepartment of Genetics, Yale School of Medicine, New Haven, Connecticut.ORCID 0000-0001-7744-1363
Andrew BenzCellarity, Somerville, Massachusetts.ORCID 0009-0002-8118-1861
Annelie MollbrinkSciLifeLab, KTH Royal Institute of Technology, Stockholm, Sweden.ORCID 0009-0007-0542-0695
Joakim LundebergSciLifeLab, KTH Royal Institute of Technology, Stockholm, Sweden.ORCID 0000-0003-4313-1601
David van DijkComputational Biology and Bioinformatics Program, Yale University, New Haven, Connecticut.ORCID 0000-0003-3911-9925
Jeff HolstUniversity of New South Wales, Kensington, Australia.ORCID 0000-0002-0377-9318
Leonard D GoldsteinKinghorn Cancer Centre, Garvan Institute of Medical Research, Darlinghurst, Australia.ORCID 0000-0003-4645-553X
Sarah KummerfeldKinghorn Cancer Centre, Garvan Institute of Medical Research, Darlinghurst, Australia.ORCID 0000-0002-0089-2358
Smita KrishnaswamyComputational Biology and Bioinformatics Program, Yale University, New Haven, Connecticut.ORCID 0000-0001-5823-1985
Christine L ChafferKinghorn Cancer Centre, Garvan Institute of Medical Research, Darlinghurst, Australia.ORCID 0000-0003-2620-6130

Funding

National Health and Medical Research Council (NHMRC) GNT1181230National Health and Medical Research Council (NHMRC) GNT1184009National Health and Medical Research Council (NHMRC) GNT2012848National Health and Medical Research Council (NHMRC) GNT2019437National Health and Medical Research Council (NHMRC) GNT2028506National Health and Medical Research Council (NHMRC) GNT2033083
6 · The paper itself

Abstract

Identifying functionally important cell states and structure within heterogeneous tumors remains a significant biological and computational challenge. Current clustering- or trajectory-based models are ill-equipped to address the notion that cancer cells reside along a phenotypic continuum. We present Archetypal Analysis network (AAnet), a neural network that learns archetypal states within a phenotypic continuum in single-cell data. Unlike traditional archetypal analysis, AAnet learns archetypes (AT) in a simplex-shaped neural network latent space. Using preclinical and clinical models of breast cancer, AAnet resolves distinct cell states and processes, including cell proliferation, hypoxia, metabolism, and immune interactions. Primary tumor ATs are recapitulated in matched liver, lung, and lymph node metastases. Spatial transcriptomics reveals archetypal organization within the tumor and intra-archetypal mirroring between cancer and adjacent stromal cells. AAnet identifies GLUT3 within the hypoxic AT that proves critical for tumor growth and metastasis. AAnet is a powerful tool, capturing complex, functional cell states from multimodal data. SIGNIFICANCE: Defining critical cell states among cells that reside along a phenotypic continuum is a current biological and computational challenge. In this study, we present AAnet, a neural network that learns archetypal cell states of cancer cells. AAnet defines discrete spatially localized ATs that resolve intratumoral heterogeneity.

Indexed as

Breast NeoplasmsNeural Networks, ComputerAnimalsFemaleHumansMiceSingle-Cell Analysis

Identifiers

PMID40552975
PMCPMC12498099

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.